Patents by Inventor Ryan L. Boudreau

Ryan L. Boudreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF
    Publication number: 20230374509
    Abstract: The present invention relates to an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of Parkinson's disease (PD) by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of retinal degeneration by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181).
    Type: Application
    Filed: March 10, 2023
    Publication date: November 23, 2023
    Inventors: Ryan L. Boudreau, Colleen S. Stein, Budd Tucker
  • THERAPEUTIC COMPOUNDS
    Publication number: 20160251653
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
    Type: Application
    Filed: September 24, 2015
    Publication date: September 1, 2016
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Beverly L. Davidson, Ryan L. Boudreau
  • Therapeutic compounds
    Patent number: 9181544
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: November 10, 2015
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Ryan L. Boudreau
  • RNA interference suppression of neurodegenerative diseases and methods of use thereof
    Patent number: 9169483
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: October 27, 2015
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Alejandro Mas Monteys, Ryan L. Boudreau
  • RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
    Publication number: 20140163214
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
    Type: Application
    Filed: July 2, 2013
    Publication date: June 12, 2014
    Applicant: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Alejandro Mas Monteys, Ryan L. Boudreau
  • THERAPEUTIC COMPOUNDS
    Publication number: 20140142288
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
    Type: Application
    Filed: February 13, 2012
    Publication date: May 22, 2014
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Beverly L. Davidson, Ryan L. Boudreau
  • RNA interference suppresion of neurodegenerative diseases and methods of use thereof
    Patent number: 8524879
    Abstract: The present invention is directed to small interfering RNA molecules (siRNA) targeted against nucleic acid sequence that encodes huntingtin or ataxin-1, and methods of using these siRNA molecules.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: September 3, 2013
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Haibin Xia, Qinwen Mao, Henry Paulson, Ryan L. Boudreau, Scott Harper
  • RNA interference suppression of neurodegenerative diseases and methods of use thereof
    Patent number: 8487088
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: July 16, 2013
    Assignee: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Alejandro Mas Monteys, Ryan L. Boudreau
  • RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
    Publication number: 20110244562
    Abstract: The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
    Type: Application
    Filed: December 23, 2010
    Publication date: October 6, 2011
    Applicant: University of Iowa Research Foundation
    Inventors: Beverly L. Davidson, Alejandro Mas Monteys, Ryan L. Boudreau